Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043498 · ClinicalTrials.gov registry record
Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children
A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 727
- Enrollment target
NCT00043498: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00043498 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 727 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00043498 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 727 participants
- Enrollment target
Study Summary
A molecular epidemiologic study of African American and Hispanic mothers and newborns to investigate the role of common urban pollutants on procarcinogenic and developmental damage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 727 participants |
| Start Date | 1997-08 |
| Est. Completion | 2013-05 |
What the finished NCT00043498 record still lists
NCT00043498 is an observational study that tracks outcomes without assigning an intervention. The registered 727 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00043498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00043498 about?
NCT00043498 is a clinical study titled "Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children". A molecular epidemiologic study of African American and Hispanic mothers and newborns to investigate the role of common urban pollutants on procarcinogenic and developmental damage.
What is the current status of trial NCT00043498?
This trial is currently completed. The enrollment target is 727 participants. The study started on 1997-08. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00043498?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- NCT06433765 · 728 participants
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
- NCT06660342 · 728 participants
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia